Moderna
MRNA
$25.01
Share price
1.19%
Change (1 day)
-76.06%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
P/S ratio for Moderna (MRNA)
P/S ratio as of April 2025 (TTM): 3.05
According to Moderna 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.8938. At the end of 2024 the company had a P/S ratio of 4.83.
P/S ratio history for Moderna from 2018 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 4.83 | -14.02% |
| 2023 | 5.61 | 53.56% |
| 2022 | 3.66 | -37.03% |
| 2021 | 5.81 | -96.15% |
| 2020 | 151 | 9.95% |
| 2019 | 137 | 235.08% |
| 2018 | 40.9 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |
 | 3.03 | -0.48% | 🇺🇸 USA |
 | 10.4 | 241.97% | 🇺🇸 USA |
 | 13.3 | 335.76% | 🇺🇸 USA |
 | 4.22 | 38.71% | 🇨🇭 Switzerland |
 | 664 | 21,704.01% | 🇺🇸 USA |
 | 4.23 | 38.82% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |